As detailed in a Stanford-led study published in Nature, researchers successfully created a replica of a neuronal pathway responsible for pain transmission in a lab dish called an “assembloid.” The ...
Please provide your email address to receive an email when new articles are posted on . British researchers found that beta-blockers were associated with a reduced risk for primary care consultations ...
On Jan. 30, the U.S. Food and Drug Administration (FDA) approved a new drug called suzetrigine to treat moderate-to-severe pain. The prescription pills, sold under the brand name Journavx and made by ...
New research suggests pain is not a simple signal of injury but a process that unfolds across nerves, spinal cord, and brain. Scientists are now targeting earlier points in that pathway, before pain ...
Pain is an important physiological response in living organisms. While physical pain is an outcome of tissue damage, pain can manifest as diverse unpleasant sensory and emotional experiences. Many ...
The opioid crisis remains a significant public health challenge in the United States. In 2022, over 2.5 million American adults had an opioid use disorder, and opioids accounted for nearly 76% of ...
Halneuron, a NaV 1.7 sodium channel inhibitor, is being tested for chemotherapy-induced neuropathic pain, offering a potential opioid alternative. Previous trials showed Halneuron significantly ...
Normal pain transmission triggers signaling modules to cause a sensation of pain. In chronic pain, activated astrocytes cause an increase in production of these signaling molecules, which leads to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results